Chemcon Speciality Chemicals Limited (NSE:CHEMCON)
India · Delayed Price · Currency is INR 203.95
+3.94 (1.97%)
Nov 12, 2026, 3:30 PM IST
NSE:CHEMCON Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 2,647 | 2,400 | 2,074 | 2,671 | 3,029 | 2,571 |
| 2,647 | 2,400 | 2,074 | 2,671 | 3,029 | 2,571 | |
Revenue Growth | 22.24% | 15.71% | -22.35% | -11.82% | 17.80% | 5.59% |
Cost of Revenue | 1,697 | 1,584 | 1,232 | 1,912 | 1,779 | 1,263 |
Gross Profit | 949.72 | 815.87 | 842.4 | 758.95 | 1,250 | 1,308 |
Selling, General & Admin | 218.16 | 206.74 | 203.26 | 185.16 | 209.31 | 194.46 |
Other Operating Expenses | 305.74 | 301.67 | 309.55 | 299.92 | 333.03 | 290.62 |
Operating Expenses | 660.03 | 623.94 | 617.92 | 588.17 | 626.05 | 547.78 |
Operating Income | 289.69 | 191.92 | 224.48 | 170.78 | 623.6 | 760.58 |
Interest Expense | -30.83 | -19.92 | -34.49 | -34.55 | -14.34 | -5.4 |
Interest & Investment Income | 120.95 | 120.95 | 133.53 | 122.28 | 94.37 | 81.47 |
Currency Exchange Gain (Loss) | 24.71 | 24.71 | 8.49 | 4.21 | 32.06 | 10.76 |
Other Non Operating Income (Expenses) | -5.05 | -1.21 | -0.44 | -0.42 | -0.36 | -0.29 |
EBT Excluding Unusual Items | 399.46 | 316.45 | 331.56 | 262.31 | 735.32 | 847.12 |
Gain (Loss) on Sale of Investments | 4.4 | 4.4 | 0.92 | - | - | - |
Gain (Loss) on Sale of Assets | 0.25 | 0.25 | -0.41 | 0.27 | 6.53 | -3.09 |
Asset Writedown | -1.51 | -1.51 | -0.61 | - | -0.34 | -4.08 |
Pretax Income | 402.6 | 319.59 | 331.46 | 262.58 | 741.51 | 839.96 |
Income Tax Expense | 103.14 | 83.61 | 86.94 | 70.65 | 190.41 | 212.39 |
Net Income | 299.47 | 235.98 | 244.52 | 191.93 | 551.1 | 627.57 |
Net Income to Common | 299.47 | 235.98 | 244.52 | 191.93 | 551.1 | 627.57 |
Net Income Growth | 20.33% | -3.49% | 27.40% | -65.17% | -12.18% | 11.27% |
Shares Outstanding (Basic) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Outstanding (Diluted) | 37 | 37 | 37 | 37 | 37 | 37 |
Shares Change | -0.06% | - | - | - | -0.00% | 7.03% |
EPS (Basic) | 8.18 | 6.44 | 6.68 | 5.24 | 15.04 | 17.13 |
EPS (Diluted) | 8.18 | 6.44 | 6.68 | 5.24 | 15.04 | 17.13 |
EPS Growth | 20.37% | -3.52% | 27.40% | -65.16% | -12.20% | 3.95% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 429.36 | 323.55 | 287.47 | -308.77 | -334.54 | 240.41 |
Free Cash Flow Per Share | 11.73 | 8.83 | 7.85 | -8.43 | -9.13 | 6.56 |
Dividend Per Share | - | 6.500 | - | - | 4.000 | - |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 35.88% | 34.00% | 40.62% | 28.42% | 41.26% | 50.89% |
Operating Margin | 10.95% | 8.00% | 10.82% | 6.39% | 20.59% | 29.58% |
Profit Margin | 11.31% | 9.83% | 11.79% | 7.19% | 18.20% | 24.41% |
Free Cash Flow Margin | 16.22% | 13.48% | 13.86% | -11.56% | -11.04% | 9.35% |
EBITDA | 425.76 | 307.41 | 329.53 | 273.44 | 704.77 | 819.65 |
EBITDA Margin | 16.09% | 12.81% | 15.89% | 10.24% | 23.27% | 31.88% |
D&A For EBITDA | 136.08 | 115.48 | 105.06 | 102.66 | 81.17 | 59.07 |
EBIT | 289.69 | 191.92 | 224.48 | 170.78 | 623.6 | 760.58 |
EBIT Margin | 10.95% | 8.00% | 10.82% | 6.39% | 20.59% | 29.58% |
Effective Tax Rate | 25.62% | 26.16% | 26.23% | 26.91% | 25.68% | 25.29% |
Revenue as Reported | 2,798 | 2,554 | 2,217 | 2,803 | 3,162 | 2,663 |
Advertising Expenses | - | 2.12 | 4.7 | - | - | - |